1 Primary outcome (response) at 2 weeks |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.14 [0.64, 2.04] |
1.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.14 [0.64, 2.04] |
2 Primary outcome (response) at end of the acute-phase treatment |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.50 [0.95, 2.37] |
2.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.50 [0.95, 2.37] |
3 Secondary outcome (remission) at 2 weeks |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.0 [0.36, 2.80] |
3.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.0 [0.36, 2.80] |
4 Secondary outcome (remission) at end of the acute-phase treatment |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.38 [0.76, 2.52] |
4.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
1.38 [0.76, 2.52] |
5 Secondary outcome (withdrawal due to any reason) |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.90 [0.47, 1.72] |
5.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.90 [0.47, 1.72] |
6 Secondary outcome (withdrawal due to adverse events) |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.61 [0.25, 1.51] |
6.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.61 [0.25, 1.51] |
7 Hypertension/Tachycardia |
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.31 [0.06, 1.59] |
7.1 vs Trazodone
|
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.31 [0.06, 1.59] |
8 Hypotension/Bradycardia |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.17 [0.03, 1.00] |
8.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.17 [0.03, 1.00] |
9 Constipation |
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.70 [0.26, 1.83] |
9.1 vs Trazodone
|
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.70 [0.26, 1.83] |
10 Dry mouth/Decreased salivation |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.39 [0.11, 1.37] |
10.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.39 [0.11, 1.37] |
11 Nausea/Vomiting/Gastric distress |
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.68 [0.20, 2.32] |
11.1 vs Trazodone
|
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.68 [0.20, 2.32] |
12 Weight gain/Increased appetite |
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
4.95 [1.30, 18.81] |
12.1 vs Trazodone
|
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
4.95 [1.30, 18.81] |
13 Weight loss/Anorexia |
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.33 [0.01, 8.21] |
13.1 vs Trazodone
|
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.33 [0.01, 8.21] |
14 Anxiety/Agitation |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.62 [0.19, 1.96] |
14.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.62 [0.19, 1.96] |
15 Dizziness/Vertigo/Faintness |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.64 [0.30, 1.39] |
15.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.64 [0.30, 1.39] |
16 Headache |
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.65 [0.23, 1.87] |
16.1 vs Trazodone
|
1 |
100 |
Odds Ratio (M-H, Random, 95% CI) |
0.65 [0.23, 1.87] |
17 Sleep disturbance |
1 |
200 |
Odds Ratio (M-H, Random, 95% CI) |
0.42 [0.13, 1.42] |
17.1 vs Trazodone
|
1 |
200 |
Odds Ratio (M-H, Random, 95% CI) |
0.42 [0.13, 1.42] |
18 Sleepiness/Drowsiness/Somnolence |
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.62 [0.29, 1.36] |
18.1 vs Trazodone
|
2 |
300 |
Odds Ratio (M-H, Random, 95% CI) |
0.62 [0.29, 1.36] |
19 Completed suicide |
1 |
200 |
Odds Ratio (M-H, Random, 95% CI) |
3.03 [0.12, 75.28] |
19.1 vs Trazodone
|
1 |
200 |
Odds Ratio (M-H, Random, 95% CI) |
3.03 [0.12, 75.28] |
20 Suicide attempt |
1 |
200 |
Odds Ratio (M-H, Random, 95% CI) |
2.02 [0.18, 22.65] |
20.1 vs Trazodone
|
1 |
200 |
Odds Ratio (M-H, Random, 95% CI) |
2.02 [0.18, 22.65] |